188 related articles for article (PubMed ID: 28492870)
1. Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease.
Tan NYQ; Leong YY; Lang SS; Htoon ZM; Young SM; Sundar G
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2527-2533. PubMed ID: 28492870
[TBL] [Abstract][Full Text] [Related]
2. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.
Berger M; Matlach J; Pitz S; Berres M; Axmacher F; Kahaly GJ; Brockmann MA; Müller-Eschner M
Sci Rep; 2022 Apr; 12(1):6259. PubMed ID: 35428798
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric proptosis in thyroid eye disease.
Rana K; Garg D; Yong LSS; Leyden J; Patel S; Slattery J; Davis G; Chan WO; Selva D
Int Ophthalmol; 2024 Apr; 44(1):206. PubMed ID: 38678129
[TBL] [Abstract][Full Text] [Related]
4. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
Starks VS; Reinshagen KL; Lee NG; Freitag SK
Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
[No Abstract] [Full Text] [Related]
5. Bony Orbital Volume Expansion in Thyroid Eye Disease.
Ugradar S; Goldberg RA; Rootman DB
Ophthalmic Plast Reconstr Surg; 2019; 35(5):434-437. PubMed ID: 30550499
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological characteristics of Graves' orbitopathy patients showing spontaneous decompression.
Kang EM; Yoon JS
J Craniomaxillofac Surg; 2015 Jan; 43(1):48-52. PubMed ID: 25457466
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease.
Lee JY; Bae K; Park KA; Lyu IJ; Oh SY
PLoS One; 2016; 11(1):e0148167. PubMed ID: 26820406
[TBL] [Abstract][Full Text] [Related]
8. Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Ophthalmology; 2012 Oct; 119(10):2174-8. PubMed ID: 22709420
[TBL] [Abstract][Full Text] [Related]
9. Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease.
Cohen LM; Liou VD; Cunnane ME; Yoon MK
Orbit; 2022 Feb; 41(1):53-58. PubMed ID: 32878536
[TBL] [Abstract][Full Text] [Related]
10. Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease.
Bingham CM; Harris MA; Realini T; Nguyen J; Hogg JP; Sivak-Callcott JA
Ophthalmic Plast Reconstr Surg; 2014; 30(2):116-8. PubMed ID: 24448234
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.
Moeen Rad A; Zarei-Ghanavati S; Sabermoghaddam A; Ghavami Shahri SH; Bakhtiari E; Kiarudi MY
Int Ophthalmol; 2023 Oct; 43(10):3615-3621. PubMed ID: 37393605
[TBL] [Abstract][Full Text] [Related]
12. Superior oblique enlargement in thyroid eye disease.
Del Porto L; Hinds AM; Raoof N; Barras C; Davagnanam I; Hancox J; Adams G
J AAPOS; 2019 Oct; 23(5):252.e1-252.e4. PubMed ID: 31344455
[TBL] [Abstract][Full Text] [Related]
13. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
[TBL] [Abstract][Full Text] [Related]
14. Deep-Learning Based Automated Segmentation and Quantitative Volumetric Analysis of Orbital Muscle and Fat for Diagnosis of Thyroid Eye Disease.
Alkhadrawi AM; Lin LY; Langarica SA; Kim K; Ha SK; Lee NG; Do S
Invest Ophthalmol Vis Sci; 2024 May; 65(5):6. PubMed ID: 38696188
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Medial Wall Bowing and Clinical Associations in Thyroid Eye Disease.
Bokman CL; Ugradar S; Rootman DB
Ophthalmic Plast Reconstr Surg; 2018; 34(6):557-559. PubMed ID: 29505466
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
17. Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.
Jain AP; Gellada N; Ugradar S; Kumar A; Kahaly G; Douglas R
Br J Ophthalmol; 2022 Feb; 106(2):165-171. PubMed ID: 33172865
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Periorbital Soft Tissue in Thyroid Eye Disease.
Mimura M; Yang PT; Ko AC; Korn BS; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2020; 36(1):30-33. PubMed ID: 31567914
[TBL] [Abstract][Full Text] [Related]
19. Measurement of width and distance of the posterior border of the deep lateral orbital wall using computed tomography.
Lee H; Lee Y; Ha S; Park M; Baek S
J Craniomaxillofac Surg; 2011 Dec; 39(8):606-9. PubMed ID: 21875811
[TBL] [Abstract][Full Text] [Related]
20. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
